IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs

B079C9C84H
IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs
  • Designer: IGI&CO
  • Item: 11499/11
  • Sole: Gum Rubber
  • Closure: zip
  • Heel Type: Tacco medio
  • Material Composition: Metallic leather
  • Season: Spring/Summer
IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs IGI CO Shoes Woman Low Sneakers with Wedge 1149911 Silver Silver XPbBRZs
Follow us on web
Newsletter
Calendar
Language
Newsletter
Browse
Pharmaceuticals

Explore Other Industries

Indian pharmaceutical industry supplies over 50 per cent of global demand vaccines.

Latest update: June, 2018

Notes: Source:

Industry

Browse:

Related News

Last Updated: July 03, 2018

Last Updated: June, 2018

Introduction

India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK.

India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

Market Size

The pharmaceutical sector was valued at US$ 33 billion in 2017. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-18 and are expected to reach US$ 20 billion by 2020.

Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion).

Investments

The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.

The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 15.59 billion between April 2000 and December 2017, according to data released by the Department of Industrial Policy and Promotion (DIPP).

Some of the recent developments/investments in the Indian pharmaceutical sector are as follows:

Government Initiatives

Some of the initiatives taken by the government to promote the pharmaceutical sector in India are as follows:

Road Ahead

Medicine spending in India is expected to increase at 9-12 per cent CAGR between 2018-22 to US$ 26-30 billion, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.

The Indian government has taken many steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies.

Exchange Rate Used: INR 1 = US$ 0.0155 as on March 30, 2018

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.

Industry

Browse:

Related News

Last Updated: July 03, 2018

Pharma Clusters
Industry Contacts

WINNING THE WORLD

Indian pharma company have won around 40 per cent of all Abbreviated New Drug Approval (ANDA) from the US Food and Drug Administration (FDA) between j...

+ More >

India Now Magazine

The Luxe Edge - Reshaping India's Lifestyle Choices

English

+ More Publications >

Fintech, i.e. the technology that enables banking and financial services, is a very fast growing space in India, especially for the start-up domain. Fintechs are offering...

The Indian technology start-up domain is proudly placed at the fourth largest position in the world. The industry was sized at US$ 35 billion in FY18. Last decade saw eme...

Textiles have been one of the oldest and largest industries in India historically, second only to agriculture, and it generates jobs for millions of people. The current e...

Today is the most opportune time for India to revolutionise its science and technology ecosystem. The size of our economy provides the capital, manpower and market to inv...

Daimler India Commercial Vehicle has been able to create a space for its offerings in the already crowded domestic commercial vehicle market. Erich Nesselhauf, MD C...

TUV Rheinland India is a subsidiary of the TUV Rheinland Group, Germany. As part of the India, Middle East, Africa Asia Pacific Group, it caters to the Indian marke...

Netmed.com (India ki pharmacy), is an online portal for medicines where one can upload the prescription, order medicines, and get them delivered at the doorstep. The company came into being in 2015 and since then it is trying to make all the modern medicines available and affordable for all with a hybrid inventory/marketplace model...

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member? Login / Retrieve Password

Copyright © 2010-2018 India Brand Equity Foundation

This website uses cookies

URBANARA.co.uk uses cookies to improve your shopping experience. By continuing to use the site, you consent to our use of cookies.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Inactive cookies are cookies that are currently being classified, as well as cookies that have been deactivated, e.g. due to expired or paused marketing campaigns. These cookies are currently not in use.
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
Cookie declaration last updated on 15/06/2018 by Cookiebot
Call us for free 0800 77 97 527 | LOGIN

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Spring Summer '18

Shop by Category

Shop by Collection

Last Chance: Living

Shop by Category

Shop by Collection

Journal > RTRY WomenS Boots Spring Fall Winter Platform Comfort Novelty Patent Leather Leatherette Wedding Office amp;Amp; Career Party amp;Amp; Evening Dress Casual US45 / EU36 / UK35 Big Kids uLstYy
> Polyester

Company

Lilley Womens Black Faux Suede T Bar Court Shoe Black C4kEMmjWNZ
Unique Trust
Press
Partnerships
Nine West Womens Craven Leather Ballet Flat Black 04uhC4tj

Products

Melluso R25400 Sneakers Women Grey L5oF2RXxz
Artificial Intelligence
Security for Digital identities
EMV Payment
Secure Microcontrollers
Converse Unisex Adults Skate One Star Cc Pro Ox Leather Fitness Shoes White White/Dolphin/White 102 GalhOi9
Secure Crypto NFC modules
Caterpillar Womens/Ladies Pastime Lightweight Flexible Ankle Boots Cloud QEvcd

Solutions

Digital Brand Protection
Security for Financial Institutions
Everlast EV060 Clogs Women Silver 5ta59pZCpa
Gola Sport Panas Black Pink Trainers Blue 6sA3VvF
VogueZone009 Womens Imitated Suede NoHeel Pointed Closed Toe Solid Laceup Flats Shoes Blue vWjebGf3
Salabobo QYY2080 New Mens Stylish Casual Loafers Comfy Slipon Moccasins Driving Shoes Blue o8KNnrq

Investors

Women Cute Cork Sandals OpenToe Beach Slippers Shoes Flat Flip Flops Color7 i9gIGb
MTNG Womens Sports Shoes Colour Light Brown Brand Model Womens Sports Shoes Manti Light Brown Light Brown Mz41h2Xb
KSWISS BigShot Light 25 Omni Ladies Shoe White/Blue UK8 CGqyQwx6gO
Shareholders Contacts

WISeKey SA

Route de Pré-Bois 29, P.O. Box 853 CH-1215 Geneva 15, Switzerland Phone: +41 22 594 3000 Fax: +41 22 594 3001 General Information: info@wisekey.com Sales: Dolly50G 5 Heel wwccaOOY
Technical Support: support@wisekey.com

Social

Copyright © 1999 - 2018 by WISeKey. All Rights Reserved. Repository | Legal disclaimer | Privacy | adidas Superstar Vulc Adv Men’s Skateboarding White Ftwbla/Reauni/Dormet hhTXWs5